Related Experiment Video
Updated: Nov 30, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Non-SARS-CoV-2 genome sequences identified in clinical samples from COVID-19 infected patients: Evidence for
1Department of Biomedical and Diagnostic Sciences College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA.
Insights
This study found that patients infected with SARS-CoV-2 (the virus causing COVID-19) frequently had co-infections with other viruses and bacteria. These findings highlight the complex microbial landscape during COVID-19 infection.
Area of Science:
- Virology
- Microbiology
- Genomics
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, emerged in late 2019.
- Co-infections significantly influence viral disease severity and host immune responses.
Purpose of the Study:
- To investigate the presence of co-infections in patients with SARS-CoV-2.
- To characterize the viral and bacterial communities in SARS-CoV-2 infected individuals.
Main Methods:
- Retrieved 68 SARS-CoV-2 patient sequencing datasets from NCBI SRA.
- Utilized alignment-free k-mer analysis (fastv) for data screening.
- Employed Kraken 2 for taxonomic classification of non-SARS-CoV-2 sequences.
Main Results:
- SARS-CoV-2 was detected in most patients.
- Co-infections included influenza A (H7N9), HIV, metapneumovirus, adenovirus, herpesvirus 1, coronavirus NL63, parvovirus, SV40, and hepatitis viruses.
- A diverse range of bacterial populations were also identified.
Conclusions:
- SARS-CoV-2 infected patients exhibit frequent co-infections with various viruses and bacteria.
- Understanding these co-infections is crucial for managing COVID-19 and its complications.
Background:
In December 2019, an ongoing outbreak of pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/ 2019-nCoV) infection was initially reported in Wuhan, Hubei Province, China. Early in 2020, the World Health Organization (WHO) announced a new name for the 2019-nCoV-caused disease: coronavirus disease 2019 (COVID-19) and declared COVID-19 to be a Public Health Emergency of International Concern (PHEIC). Cellular co-infection is a critical determinant of viral fitness and infection outcomes and plays a crucial role in shaping the host immune response to infections.
Methods:
In this study, 68 public next-generation sequencing data from SARS-CoV-2 infected patients were retrieved from the NCBI Sequence Read Archive database using SRA-Toolkit. Data screening was performed using an alignment-free method based on k-mer mapping and extension, fastv. Taxonomic classification was performed using Kraken 2 on all reads containing one or more virus sequences other than SARS-CoV-2.
Results:
SARS-CoV-2 was identified in all except three patients. Influenza type A (H7N9) virus, human immunodeficiency virus, rhabdovirus, human metapneumovirus, Human adenovirus, Human herpesvirus 1, coronavirus NL63, parvovirus, simian virus 40, and hepatitis virus genomes sequences were detected in SARS-CoV-2 infected patients. Besides, a very diverse group of bacterial populations were observed in the samples.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Viral Recombination
Viral Mutations
Viruses with RNA Genomes
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Genomics

